Hodgkin Lymphoma Drug Update

The CEO of Seattle Genetics Inc., talks with Bloomberg's Adam Johnson about clinical trial data for the company's brentuximab vedotin treatment for Hodgkin lymphoma.

More Videos

LymphomaInfo Social